| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |